Login

Quazi Mohammad Shahed, CEO of Partex Star Group, discusses with Somoy TV at Complex-1. 00:10:00

Share On Facebook Share On Twitter

Star Group's Chairman, Director is Paul Vermylen

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
The Role of Electric Vehicles in Addressing Environmental Challenges
00:10:00
Commerce Resources Achieves Milestone in Rare Earth Production at Ashram Deposit | Chris Grove, President & CEO of Commerce Resources Corp.
00:10:00
Adtalem CEO Steve Beard on Q4 Earnings, College Enrollment, and Addressing the Healthcare Worker Shortage | Steve Beard , CEO, Adtalem Global Education.
00:10:00
Sopheon PLC chief executive Greg Coticchia discusses operations, while Itaconix CEO outlines future growth despite short-term challenges.
00:10:00
Osprey Goldfields CEO Discusses Strategic Exploration and Promising Prospects in Victoria, Australia
00:10:00
Family Legacy of Crafting Personalized Memorials: Munoz and Travis Monuments
00:10:00
Quick High-Level Valuation of Kelly Partners Group: Is It Worth a Deeper Dive?
00:10:00
Digbee ESG Platform: Enhancing ESG Disclosure in the Mining Industry
00:10:00
Driving Success: Norm Alpert and Pat Ryan on Vestar's Impact at Press Ganey | Norm Alpert, Founding Partner, Vestar Capital Partner.
00:10:00
Julien Guerrand of TCM Capital and Martin Baumann, Co-Founder of CMCC Global, share insights as hedge fund and capital management leaders.
00:10:00
Tura Group’s CEO Stefan Eriksson on Achievements and Market Outlook | Stefan Eriksson, CEO, Tura Group AB.
00:10:00
Opportunities in Texas Venture Capital|Mike Boyle,Managing Partner,Ecliptic Capital

© 2017 - Neuhu+